Concepedia

Janina Stumpf

JS

Statistics

Publications

5

Citations

122

H-Index

5

Active since

2023

Affiliations

Düsseldorf University Hospital(Current)

Heinrich Heine University Düsseldorf

University Hospital Cologne

Christian-Albrechts-Universität zu Kiel

University Hospital Schleswig-Holstein

Janina Stumpf is an author at Düsseldorf University Hospital specializing in oncology, lymphoma chemotherapy, and chemotherapy.

Publications per year

2023–2025

5

Publications

5

Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial

Othman Al‐Sawaf, Rudy Ligtvoet, Sandra Robrecht et al. · Nature Medicine · 2023 · 47 citations · Full text

, , +14

Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia

Othman Al‐Sawaf, Janina Stumpf, Can Zhang et al. · New England Journal of Medicine · 2025 · 35 citations

, , +16

Acalabrutinib, venetoclax, and obinutuzumab in relapsed/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trial

Moritz Fürstenau, Adam Giza, Jonathan M. Weiss et al. · Blood · 2024 · 20 citations

, , +17

MRD-guided zanubrutinib, venetoclax, and obinutuzumab in relapsed CLL: primary end point analysis from the CLL2-BZAG trial

Moritz Fürstenau, Sandra Robrecht, Christof Schneider et al. · Blood · 2025 · 10 citations

, , +17

Acalabrutinib treatment for older (aged ≥80 years) and/or frail patients with CLL: primary end point analysis of the CLL-Frail trial

Florian Simon, Rudy Ligtvoet, Jan‐Paul Bohn et al. · Blood · 2025 · 10 citations · Full text

, , +12

1–5 of 5